Search research articles
Contact Us
Filters
Showing results (51-60 of 251) with videos related to
Page
of 26
Sort By:
Leukemia & Lymphoma
|
May 16, 2012
Combination of cytarabine and topotecan in patients treated for acute myeloid leukemia with persistent disease after frontline induction
Thomas Prébet, Estelle Jean, Aurélie Autret, et al.
Haematologica
|
November 21, 2007
Adding lomustine to idarubicin and cytarabine for induction chemotherapy in older patients with acute myeloid leukemia: the BGMT 95 trial results
Arnaud Pigneux, Virginie Perreau, Eric Jourdan, et al.
HLA
|
November 10, 2023
Comparison of HLA antibody identification methods for the selection of platelet products for HLA-mediated platelet refractory patients
Pascal Pedini, Lucas Hubert, Jean-Baptiste Baudey, et al.
Clinical Lymphoma, Myeloma & Leukemia
|
December 23, 2019
Alternative Effective and Safe Induction Regimens for Newly Diagnosed Acute Myeloid Leukemia in Patients With Cardiac Contraindication to Anthracyclines
Clemence Marcault, Geoffroy Venton, Lauris Gastaud, et al.
Cancer
|
February 28, 2007
Comorbidity is an independent predictor of complete remission in elderly patients receiving induction chemotherapy for acute myeloid leukemia
Anne Etienne, Benjamin Esterni, Aude Charbonnier, et al.
Leukemia & Lymphoma
|
December 3, 2016
Phase 1 dose-escalation study of oral abexinostat for the treatment of patients with relapsed/refractory higher-risk myelodysplastic syndromes, acute myeloid leukemia, or acute lymphoblastic leukemia
Norbert Vey, Thomas Prebet, Claire Thalamas, et al.
American Journal of Hematology
|
November 18, 2017
Impact of gene mutations on treatment response and prognosis of acute myeloid leukemia secondary to myeloproliferative neoplasms
Geoffroy Venton, Frédéric Courtier, Aude Charbonnier, et al.
Cancer
|
October 30, 2007
Secondary or concomitant neoplasms among adults diagnosed with acute lymphoblastic leukemia and treated according to the LALA-87 and LALA-94 trials
Emmanuelle Tavernier, Quoc-Hung Le, Stéphane de Botton, et al.
Bone Marrow Transplantation
|
April 29, 2018
Critically ill allogenic HSCT patients in the intensive care unit: a systematic review and meta-analysis of prognostic factors of mortality
Colombe Saillard, Michael Darmon, Magali Bisbal, et al.
Bone Marrow Transplantation
|
August 8, 2018
Clinical outcome of FLAG-IDA chemotherapy sequential with Flu-Bu3 conditioning regimen in patients with refractory AML: a parallel study from Shanghai Institute of Hematology and Institut Paoli-Calmettes
Ling Wang, Raynier Devillier, Ming Wan, et al.
Page
of 26
Search research articles
Search
Showing results (51-60 of 251) with videos related to
Sort By:
Page
of 26
Leukemia & Lymphoma
|
May 16, 2012
Combination of cytarabine and topotecan in patients treated for acute myeloid leukemia with persistent disease after frontline induction
Thomas Prébet, Estelle Jean, Aurélie Autret, et al.
Haematologica
|
November 21, 2007
Adding lomustine to idarubicin and cytarabine for induction chemotherapy in older patients with acute myeloid leukemia: the BGMT 95 trial results
Arnaud Pigneux, Virginie Perreau, Eric Jourdan, et al.
HLA
|
November 10, 2023
Comparison of HLA antibody identification methods for the selection of platelet products for HLA-mediated platelet refractory patients
Pascal Pedini, Lucas Hubert, Jean-Baptiste Baudey, et al.
Clinical Lymphoma, Myeloma & Leukemia
|
December 23, 2019
Alternative Effective and Safe Induction Regimens for Newly Diagnosed Acute Myeloid Leukemia in Patients With Cardiac Contraindication to Anthracyclines
Clemence Marcault, Geoffroy Venton, Lauris Gastaud, et al.
Cancer
|
February 28, 2007
Comorbidity is an independent predictor of complete remission in elderly patients receiving induction chemotherapy for acute myeloid leukemia
Anne Etienne, Benjamin Esterni, Aude Charbonnier, et al.
Leukemia & Lymphoma
|
December 3, 2016
Phase 1 dose-escalation study of oral abexinostat for the treatment of patients with relapsed/refractory higher-risk myelodysplastic syndromes, acute myeloid leukemia, or acute lymphoblastic leukemia
Norbert Vey, Thomas Prebet, Claire Thalamas, et al.
American Journal of Hematology
|
November 18, 2017
Impact of gene mutations on treatment response and prognosis of acute myeloid leukemia secondary to myeloproliferative neoplasms
Geoffroy Venton, Frédéric Courtier, Aude Charbonnier, et al.
Cancer
|
October 30, 2007
Secondary or concomitant neoplasms among adults diagnosed with acute lymphoblastic leukemia and treated according to the LALA-87 and LALA-94 trials
Emmanuelle Tavernier, Quoc-Hung Le, Stéphane de Botton, et al.
Bone Marrow Transplantation
|
April 29, 2018
Critically ill allogenic HSCT patients in the intensive care unit: a systematic review and meta-analysis of prognostic factors of mortality
Colombe Saillard, Michael Darmon, Magali Bisbal, et al.
Bone Marrow Transplantation
|
August 8, 2018
Clinical outcome of FLAG-IDA chemotherapy sequential with Flu-Bu3 conditioning regimen in patients with refractory AML: a parallel study from Shanghai Institute of Hematology and Institut Paoli-Calmettes
Ling Wang, Raynier Devillier, Ming Wan, et al.
Page
of 26